#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal neuroendocrine tumour Encephalitis autoimmune Thrombotic microangiopathy Anal cancer Acute graft versus host disease Alport's syndrome Anti-glomerular basement membrane disease Huntington's disease Systemic sclerosis pulmonary Chondrodystrophy Gastric cancer Enteritis Albright's disease Transitional cell carcinoma Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Life with Disease Sarcoma – Life with Disease Systemic mastocytosis Idiopathic pulmonary fibrosis – Treatment Sarcoidosis – Diagnostics Progressive supranuclear palsy – Treatment Usher’s syndrome – Treatment X-linked lymphoproliferative syndrome – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease Angiosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIRCONIUM (89ZR) GIRENTUXIMAB Granisetron Transcon Il-2Β/Γ Pevonedistat Olaptesed Pegol Dopamine Hydrochloride Inaxaplin Doxazosin Mesilate Tipiracil Hydrochloride Ucp2 Dutasteride Protease Metyrapone Rebisufligene Etisparvovec Cefalexin Rugonersen Ketamine Hydrochloride Sargramostim Vib1116 Tetrahydrouridine More therapies…

    Learn about Your Condition

    Varicella VEXAS syndrome Malignant peritoneal neoplasm Supraventricular tachycardia Cardiovascular disorder Biotinidase deficiency Pneumococcal infection Venous thrombosis Colon cancer metastatic Neurodermatitis Choreoathetosis Osteoporosis Primary biliary cholangitis Lysosomal storage disorder Medication overuse headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Treating Chronic Lymphocytic Leukemia with Venetoclax and Acalabrutinib for Patients Whose Disease Has Returned After Initial Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Venetoclax
    Belgium Denmark The Netherlands

  • Study on Psilocybin, Ketamine, and Midazolam for Treating Depression in Cancer Patients

    Recruiting

    2 1 1
    Investigated Drugs:
    • Psilocybine
    • Ketamine Hydrochloride
    • Midazolam
    Czechia

  • A Study of FOLFIRINOX Drug Combination Before Surgery Compared to Immediate Surgery in Patients with Resectable Pancreatic Head Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Norway Sweden

  • Study on the Effects of Sodium Lactate and Saline Solutions in Patients with Septic Shock

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sodium Lactate
    Czechia

  • Study on the Effectiveness of Hypothalamic Phospholipids and Citalopram for Treating Major Depressive Disorder in Elderly Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Hypothalamic Phospholipids
    • Citalopram Hydrobromide
    Italy

  • Study on Reducing Fluid Use During Cancer Surgery with Argipressin for Patients with Disseminated Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    The Netherlands
Previous Page
1 … 413 414 415 416 417 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!